On the day that the definitive end of mandatory corona vaccination was announced in Austria, the green light was given for a new vaccine. On Thursday, the European Medicines Agency (EMA) recommended approval for the vaccine from the French-Austrian company Valneva. It is the first so-called dead vaccine that will soon be allowed to be vaccinated in the European Union – the final approval by the EU Commission is just a formality.
The competent committee of the EMA has recommended the vaccine for use as a basic vaccination in people aged 18 to 50 years. It would be the sixth approved Covid-19 vaccine in the European Union. The vaccine contains the inactivated SARS-CoV-2 virus and two enhancers.
Valneva recently questioned the future of its inactivated vaccine after the European Commission announced it could end the vaccine’s pre-purchase agreement due to delays in the approval process.
Approach tried and tested for decades
Valneva’s Covid vaccine VLA2001 is the only vaccine candidate for the whole virus (“dead vaccine”) developed in Europe. Valneva follows an approach that has been tried and tested for decades. All the dead virus is presented to the body. So the immune system has to deal with all parts of the pathogen. Production takes place in Scotland and Sweden, but according to the company most of the development work went through Vienna. VLA2001 has already been approved in Great Britain and Bahrain and since 13 May also in the United Arab Emirates.
Source: Krone
I’m Wayne Wickman, a professional journalist and author for Today Times Live. My specialty is covering global news and current events, offering readers a unique perspective on the world’s most pressing issues. I’m passionate about storytelling and helping people stay informed on the goings-on of our planet.
